Literature DB >> 22786683

Deep brain stimulation for psychiatric disease: contributions and validity of animal models.

Clement Hamani1, Yasin Temel.   

Abstract

During treatment with deep brain stimulation (DBS), electrical current is delivered into the brain parenchyma through implanted electrodes. Although this technique is routinely used in the treatment of Parkinson's disease, essential tremor, and dystonia, a growing number of neuropsychiatric applications for DBS are being investigated. Investigators can use animal models of these diseases to study the mechanisms through which DBS exerts its effects, to explore new applications of this therapy, and to identify and characterize alternative stimulation targets. Here, we discuss preclinical DBS research that provides insight into the mechanisms underlying cognitive and psychiatric applications of this technique, emphasizing the predictive validity of animal models and their potential use in translational research.

Entities:  

Mesh:

Year:  2012        PMID: 22786683     DOI: 10.1126/scitranslmed.3003722

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  51 in total

Review 1.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

2.  Cellular mechanisms of deep brain stimulation: activity-dependent focal circuit reprogramming?

Authors:  Avin Veerakumar; Olivier Berton
Journal:  Curr Opin Behav Sci       Date:  2015-08-01

3.  Augmentative therapies do not potentiate the antidepressant-like effects of deep brain stimulation in rats.

Authors:  Bryce Laver; Mustansir Diwan; José N Nobrega; Clement Hamani
Journal:  J Affect Disord       Date:  2014-03-15       Impact factor: 4.839

4.  Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation.

Authors:  Clement Hamani; Peter Giacobbe; Mustansir Diwan; Eliane S Balbino; Junchao Tong; Alanna Bridgman; Nir Lipsman; Andres M Lozano; Sidney H Kennedy; José N Nobrega
Journal:  Am J Psychiatry       Date:  2012-12       Impact factor: 18.112

5.  Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.

Authors:  Abhiram Pushparaj; Clement Hamani; Wilson Yu; Damian S Shin; Bin Kang; José N Nobrega; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2012-11-15       Impact factor: 7.853

6.  Antidepressant-like effects of cortical deep brain stimulation coincide with pro-neuroplastic adaptations of serotonin systems.

Authors:  Avin Veerakumar; Collin Challis; Preetika Gupta; Jennifer Da; Aseem Upadhyay; Sheryl G Beck; Olivier Berton
Journal:  Biol Psychiatry       Date:  2013-12-26       Impact factor: 13.382

7.  Deep brain stimulation in rats: different targets induce similar antidepressant-like effects but influence different circuits.

Authors:  Clement Hamani; Beatriz O Amorim; Anne L Wheeler; Mustansir Diwan; Klaus Driesslein; Luciene Covolan; Christopher R Butson; José N Nobrega
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

8.  Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia.

Authors:  Lior Bikovsky; Ravit Hadar; María Luisa Soto-Montenegro; Julia Klein; Ina Weiner; Manuel Desco; Javier Pascau; Christine Winter; Clement Hamani
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

9.  Prefrontal Cortex Deep Brain Stimulation Improves Fear and Anxiety-Like Behavior and Reduces Basolateral Amygdala Activity in a Preclinical Model of Posttraumatic Stress Disorder.

Authors:  Roman Reznikov; Francis Rodriguez Bambico; Mustansir Diwan; Roger J Raymond; Mina G Nashed; José N Nobrega; Clement Hamani
Journal:  Neuropsychopharmacology       Date:  2017-09-01       Impact factor: 7.853

10.  Acute high frequency stimulation of the prefrontal cortex or nucleus accumbens does not increase hippocampal neurogenesis in rats.

Authors:  Christine Winter; Tatiana Bregman; Mareike Voget; Roger Raymond; Ravit Hadar; José N Nobrega; Clement Hamani
Journal:  J Psychiatr Res       Date:  2015-05-30       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.